Related Experiment Video

Updated: Apr 21, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

710

[Antithrombocytic therapy and PCI. Duration of therapy after DCB/stents/scaffolds]

B Scheller1

  • 1Klinik für Innere Medizin III - Klinische und Experimentelle Interventionelle Kardiologie , Universitätsklinikum des Saarlandes, Gebäude 40, Kirrberger Str., 66421, Homburg/Saar, Deutschland, Bruno.Scheller@uniklinikum-saarland.de.

Herz
|October 29, 2014
PubMed

Insights

Dual antiplatelet therapy (DAPT) duration varies after percutaneous coronary interventions (PCI). Recommendations range from 4 weeks for balloon angioplasty to 6-12 months for bioresorbable vascular scaffolds.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Engineering

Context:

  • Percutaneous coronary interventions (PCI) are common procedures for treating coronary artery disease.
  • Dual antiplatelet therapy (DAPT) is crucial for preventing stent thrombosis and restenosis post-PCI.
  • The optimal duration of DAPT is debated and likely depends on the specific intervention and patient factors.

Purpose:

  • To outline the recommended durations of dual antiplatelet therapy (DAPT) following various percutaneous coronary interventions (PCI).
  • To provide clear guidelines for DAPT duration based on the type of device or treatment used during PCI.

Summary:

  • Following angioplasty alone (plain old balloon angioplasty, POBA), DAPT is recommended for 4 weeks.
  • For bare metal stents (BMS), a 4-week DAPT duration is advised.
  • Drug-eluting stents (DES) require 6 months of DAPT, while bioresorbable vascular scaffolds (BVS) necessitate 6-12 months.
  • Drug-coated balloon catheters (DCB) without a new implant also warrant a 4-week DAPT duration.

Impact:

  • Standardizing DAPT duration can optimize treatment efficacy and reduce the risk of bleeding complications.
  • This guidance aids clinicians in tailoring DAPT regimens to specific PCI types, improving patient outcomes.
  • Informing clinical practice regarding DAPT duration can enhance patient safety and procedural success rates.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
480
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
641
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
512
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
440
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
736